You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (25)

Journals (0)

1-10 of 25 results for NS3/4A protease

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Synthesis and Evaluation of Acylated Derivatives of Hederagenin as Inhibitors of HIV-1 and HCV NS3/4A Proteases

Open access

Research article

First published 2022-1

Synthesis and Evaluation of Acylated Derivatives of Hederagenin as Inhibitors of HIV-1 and HCV NS3/4A Proteases

Qing Liu, Ying Wei, Yongjia Hao [...]

Natural Product Communications

Select article: High-Throughput Cell-Based Screening for Hepatitis C Virus NS3/4A Protease Inhibitors

Retricted access

Research article

First published 2005-08

High-Throughput Cell-Based Screening for Hepatitis C Virus NS3/4A Protease Inhibitors

Jin-Ching Lee, Ming-Chen Yu, Tzu-Wen Lien [...]

ASSAY and Drug Development Technologies

Select article: Mapping Natural Polymorphisms of Hepatitis C virus NS3/4A Protease and Antiviral Resistance to Inhibitors in Worldwide Isolates

Free access

Research article

First published 2008-5

Mapping Natural Polymorphisms of Hepatitis C virus NS3/4A Protease and Antiviral Resistance to Inhibitors in Worldwide Isolates

F Xavier López-Labrador, Andrés Moya, Fernando Gonzàlez-Candelas

Antiviral Therapy

Select article: Telaprevir: An NS3/4A Protease Inhibitor for the Treatment of Chronic Hepatitis C

Retricted access

Research article

First published 2011-5

Telaprevir: An NS3/4A Protease Inhibitor for the Treatment of Chronic Hepatitis C

Lisa S Smith, Michael Nelson, Sagar Naik [...]

Annals of Pharmacotherapy

Select article: Characterization of HCV Resistance from a 3-Day Monotherapy Study of Voxilaprevir,a Novel Pangenotypic NS3/4A Protease Inhibitor

Free access

Research article

First published 2018-5

Characterization of HCV Resistance from a 3-Day Monotherapy Study of Voxilaprevir,a Novel Pangenotypic NS3/4A Protease Inhibitor

Eric Lawitz, Jenny C Yang, Luisa M Stamm [...]

Antiviral Therapy

Select article: Resistance of Hepatitis C Virus to Ns3–4A Protease Inhibitors: Mechanisms of Drug Resistance Induced by R155Q,A156T,D168A and D168V Mutations

Free access

Research article

First published 2006-10

Resistance of Hepatitis C Virus to Ns3–4A Protease Inhibitors: Mechanisms of Drug Resistance Induced by R155Q,A156T,D168A and D168V Mutations

Jérôme Courcambeck, Mourad Bouzidi, Régis Perbost [...]

Antiviral Therapy

Select article: A study on the relationship between HCV NS3 and endogenous IRF-3

Open access

Letter

First published 2018

A study on the relationship between HCV NS3 and endogenous IRF-3

Hong-Ping Liang, Hotta Hak, Jian-Min Ji

European Journal of Inflammation

Select article: A Phase I,Randomized,Placebo-Controlled,3-Day,Ascending-Dose Study of Gs-9451,An Ns3/4A Protease Inhibitor,in Genotype 1 Hepatitis C Patients

Free access

Research article

First published 2013-4

A Phase I,Randomized,Placebo-Controlled,3-Day,Ascending-Dose Study of Gs-9451,An Ns3/4A Protease Inhibitor,in Genotype 1 Hepatitis C Patients

Eric J Lawitz, John M Hill, Thomas Marbury [...]

Antiviral Therapy

Select article: Inhibition of the Bovine Viral Diarrhoea Virus NS3 Serine Protease by a Boron-Modified Peptidyl Mimetic of its Natural Substrate

Free access

Research article

First published 2001-12

Inhibition of the Bovine Viral Diarrhoea Virus NS3 Serine Protease by a Boron-Modified Peptidyl Mimetic of its Natural Substrate

Marina Bukhtiyarova, Christopher J Rizzo, Charles A Kettner [...]

Antiviral Chemistry and Chemotherapy

Select article: Grazoprevir/elbasvir combination therapy for HCV infection

Free access

Review article

First published 2017-1

Grazoprevir/elbasvir combination therapy for HCV infection

Anaïs Vallet-Pichard, Stanislas Pol

Therapeutic Advances in Gastroenterology

1
2
3
10 / page

Article type

Publication date

Subjects

Access